BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15807541)

  • 1. N-Terminal deletions modify the Cu2+ binding site in amyloid-beta.
    Karr JW; Akintoye H; Kaupp LJ; Szalai VA
    Biochemistry; 2005 Apr; 44(14):5478-87. PubMed ID: 15807541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.
    Karr JW; Kaupp LJ; Szalai VA
    J Am Chem Soc; 2004 Oct; 126(41):13534-8. PubMed ID: 15479110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
    Karr JW; Szalai VA
    Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
    Jun S; Gillespie JR; Shin BK; Saxena S
    Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.
    Maiti NC; Jiang D; Wain AJ; Patel S; Dinh KL; Zhou F
    J Phys Chem B; 2008 Jul; 112(28):8406-11. PubMed ID: 18570397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.
    Drew SC; Noble CJ; Masters CL; Hanson GR; Barnham KJ
    J Am Chem Soc; 2009 Jan; 131(3):1195-207. PubMed ID: 19119811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
    Hou L; Zagorski MG
    J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity.
    Perrone L; Mothes E; Vignes M; Mockel A; Figueroa C; Miquel MC; Maddelein ML; Faller P
    Chembiochem; 2010 Jan; 11(1):110-8. PubMed ID: 19937895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
    Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
    Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the coordination of Cu(II) by the amyloid-B 16 peptide from Fourier transform IR spectroscopy and isotopic labeling.
    El Khoury Y; Dorlet P; Faller P; Hellwig P
    J Phys Chem B; 2011 Dec; 115(49):14812-21. PubMed ID: 22026330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-beta1-16.
    Shin BK; Saxena S
    Biochemistry; 2008 Sep; 47(35):9117-23. PubMed ID: 18690709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidosis of Alzheimer's Abeta peptides: solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies.
    Antzutkin ON
    Magn Reson Chem; 2004 Feb; 42(2):231-46. PubMed ID: 14745804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-Dependent Cu(II) coordination to amyloid-β peptide: impact of sequence alterations, including the H6R and D7N familial mutations.
    Alies B; Eury H; Bijani C; Rechignat L; Faller P; Hureau C
    Inorg Chem; 2011 Nov; 50(21):11192-201. PubMed ID: 21980910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.
    Drew SC; Masters CL; Barnham KJ
    J Am Chem Soc; 2009 Jul; 131(25):8760-1. PubMed ID: 19496610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.